Skip to content

Evaluating the Impact of Pulmonary Rehabilitation in Patients with Chronic Respiratory Diseases: A Randomized Controlled Trial

Scope of Pulmonary Rehabilitation in Chronic Respiratory Disease Patients- A Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079439
Enrollment
107
Registered
2025-01-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified

Interventions

Intervention1: Home based and tele pulmonary rehabilitation training. : Intervention-1: 6 weeks of Home based pulmonary rehabilitation training. Intervention-2: 6 weeks of Tele-pulmonary rehabilitati

Sponsors

NO SPONSOR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with chronic lung disorders like Asthma, COPD, ILD, Post TB 2. Patients with post-COVID lung parenchymal diseases. 3. Patients enrolled for PR within 1 month but more than 2 weeks of hospital discharge due to exacerbation.

Exclusion criteria

Exclusion criteria: 1. Patients who have already completed more than 6 PR sessions before the current intervention. 2. Patients with Active infection like COVID-19, Pneumonia & contraindications for performing PFT. 3. Patients with Recent Acute exacerbation (less than 2 weeks of exacerbation) of COPD or ILD 4. Patients are not consistent with the PR program and attendance is less than 70% of PR sessions.

Design outcomes

Primary

MeasureTime frame
To evaluate the effects of structured pulmonary rehabilitation programs (PRP) on 6-minute walk distance and health-related quality of life in chronic lung diseases.Timepoint: Baseline and after 12 sessions (6 weeks) of PRP.

Secondary

MeasureTime frame
1. To assess the effect of structured PRP on dyspnoea progression & fatigue level by modified borg scale. 2. To measure the exercise capacity by using 6MWT. 3. To assess the lung function by spirometry. 4. To identify the barriers and facilitators to PRP in the Indian setup.Timepoint: Baseline and after 12 sessions (6 weeks) of PRP.

Countries

India

Contacts

Public ContactKumari Sulochana

Chettinad Hospital and Research Institute

respiratorymedicine@care.edu.in9840245981

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026